What time of day is best to inject Master Pharma MASS-600?

Morning injections — typically between 07:00 and 10:00 — align with naturally elevated androgen receptor sensitivity and allow the intramuscular depot to begin hydrolysis during peak daytime metabolic activity. Consistency matters more than the exact hour: choosing one fixed daily window and maintaining it throughout the cycle prevents the cumulative trough drift that occurs with variable injection times.

Does the specific day of the week affect MASS-600 cycle results?

Yes. Anchoring injections to fixed calendar days — such as Monday and Thursday — spaces doses evenly at approximately 72-hour intervals, preventing the plasma-level oscillation caused by irregular scheduling. At 600mg/ml, each 0.5ml variance in a draw represents 300mg, so anchor-day discipline directly controls the amplitude of plasma peaks and troughs across the cycle.

Should I inject MASS-600 before or after a training session?

Injecting two to four hours before training is preferred. This window positions the early hydrolysis phase of the depot to coincide with exercise-induced anabolic signalling — specifically the post-mechanical-load elevation in IGF-1 and mTOR pathway activity. Post-training injection is acceptable but introduces a timing lag relative to the peak anabolic window created by resistance work.

How do I calculate the correct draw volume from a 600mg/ml vial?

Divide your target weekly dose in milligrams by 600 to get total weekly millilitres, then divide by injection frequency. For example, a 600mg weekly dose requires 1ml total — 0.5ml per injection on a twice-weekly schedule. Pre-calculating volumes before the cycle starts minimises mid-cycle errors and reduces the number of needle punctures needed across the 10ml vial's lifespan.

What is the maximum number of draws from the MASS-600 10ml vial before sterility risk increases?

Industry aseptic practice recommends limiting multi-dose vial punctures to the number planned at cycle outset, typically no more than 20 draw events for a 10ml vial. Each penetration of the rubber stopper introduces a contamination opportunity; pre-drawn syringes stored in a refrigerator at 2–8 °C for up to 24 hours reduce total puncture count without compromising dose accuracy at this concentration. (2) angle_used

Brand Quality

Master Pharma

MASS-600 600mg/ml 10ml Vial by Master Pharma

Name: MASS-600
Brand: Master Pharma
SKU: INJ-MIX-MAS-600-014
Price: 45.00 EUR
Availability: InStock

Master Pharma MASS-600 is a single-active-ingredient injectable anabolic formulated at 600mg/ml in a 10ml multi-dose vial, distinguished by its industry-leading concentration that makes day-of-week scheduling and per-injection timing precision critical to consistent plasma levels. Because each millilitre delivers a high anabolic load, injections timed to a fixed weekly anchor day allow stable hormone exposure without the trough spikes associated with ad-hoc dosing. Batch release at Master Pharma's facility is governed by HPLC-confirmed potency against the 600mg/ml label declaration; LAL endotoxin testing and aseptic fill-finish documentation are retained per lot.

€45.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

600mg/ml concentration reduces total injection volume per dose compared to standard 200–300mg/ml products
Fixed-anchor scheduling with MASS-600 produces measurable plasma-level stability across multi-week cycles
Single active ingredient simplifies timing decisions and eliminates multi-compound half-life conflicts
10ml vial format provides sufficient volume for a full scheduled cycle without mid-cycle reorder
HPLC-confirmed label concentration ensures pre-calculated draw volumes translate to accurate milligram doses
Aseptic fill-finish under LAL-tested batch conditions supports safe repeated use across the vial's planned draw schedule
Master Pharma's Brand Quality framework applies documented lot-specific release criteria to every production batch

Phase	dosage	Note
Weeks 1–2 (Acclimation)	0.5ml per injection, twice weekly (Mon/Thu)	Establishes anchor-day habit; allows assessment of individual response at 600mg total weekly dose before escalation
Weeks 3–10 (Primary Phase)	0.75–1.0ml per injection, twice weekly (Mon/Thu)	Maintains fixed injection windows; 600–1200mg/week depending on experience and tolerance
Weeks 11–12 (Taper)	0.5ml per injection, twice weekly	Stepdown reduces depot load ahead of PCT window; preserves timing discipline to final injection

Key takeaways

Anchor injections to fixed days and hours every week.
Divide target dose by 600 before drawing to avoid volume errors.
Inject two to four hours pre-training for optimal anabolic alignment.
Expect wider plasma troughs if injection timing drifts beyond 12 hours.
Limit total vial punctures by pre-planning the full cycle draw schedule.

What MASS-600 Is and Why Timing Defines Its Effectiveness

Master Pharma MASS-600 is a high-concentration injectable anabolic delivering 600mg of active compound per millilitre, where the defining clinical variable is not merely dose but the day-and-time precision with which each injection is placed within the weekly cycle. At this concentration, even a 0.1ml draw variance represents 60mg — making clock-consistent administration more pharmacologically relevant than at lower-concentration alternatives. MASS-600 operates via androgen receptor activation in skeletal muscle tissue, with plasma levels determined directly by the ester's hydrolysis rate after intramuscular depot formation.

How Injection Timing Affects Plasma Stability at 600mg/ml

Consistent same-time, same-day injections prevent the plasma-level oscillations that accumulate across a multi-week cycle. Research into ester pharmacokinetics confirms that trough depth widens when injection intervals drift by more than 12 hours relative to the preceding dose; at 600mg/ml, that drift produces a proportionally larger absolute plasma swing than occurs at 200–300mg/ml concentrations. Master Pharma MASS-600 therefore rewards users who schedule injections to a fixed anchor point — for example, every Monday and Thursday at the same hour — more than products with lower per-ml loads. Compared to split-dosing at lower concentrations, fixed-anchor scheduling with MASS-600 achieves equivalent plasma stability with fewer total injections per week.

Pre- vs. Post-Training Injection Windows

Injection timing relative to training is a secondary but meaningful variable. Administering MASS-600 two to four hours before resistance training aligns peak local tissue perfusion with the anabolic signalling window opened by mechanical load. Post-training administration remains effective but introduces a delay before the depot begins hydrolysis during the period of highest IGF-1 and mTOR activity. Morning injections on non-training days maintain the anchor-day schedule without conflict.

Scheduling Principle for the 10ml Vial Format

A 10ml vial at 600mg/ml contains 6,000mg of total active compound. Weekly injection planning should be mapped before the first draw: total weekly dose divided by 600 determines the volume per session. This pre-calculation prevents mid-cycle volume miscalculations and preserves vial sterility by minimising the total number of punctures across the cycle.

Usage

Map the full cycle calendar before the first draw — note every injection day and hour, and calculate each session's volume by dividing the session dose in milligrams by 600.
Remove MASS-600 from storage 30–45 minutes before injection; bring the vial to room temperature to reduce oil viscosity and improve draw speed.
Swab the rubber stopper with 70% isopropyl alcohol and allow it to air-dry for 10 seconds before inserting the draw needle.
Draw the pre-calculated volume slowly, invert the vial, and inspect for particulates; a clear, oil-consistent solution confirms vial integrity.
Inject intramuscularly into a rotated site — glute, vastus lateralis, or deltoid — using a 23–25 gauge needle, administering over 30–60 seconds to minimise depot pressure.
Record the injection day, time, site, and volume drawn immediately after administration; use this log to maintain anchor-day scheduling and monitor total vial usage across the cycle.

Warnings

Contraindications: Not suitable for individuals with prostate or breast carcinoma, polycythaemia, severe hepatic impairment, or untreated hypercalcaemia. Women of childbearing age and individuals under 21 should not use this product.

Side Effects: Potential effects include androgenic activity (acne, accelerated hair thinning in predisposed individuals), endogenous testosterone suppression, elevated haematocrit, and mood variability. The 600mg/ml concentration amplifies dose-dependent effects if draw volumes are miscalculated.

Monitoring: Full blood panel including haematocrit, LFTs, lipid profile, and LH/FSH suppression markers recommended at baseline, mid-cycle (week 6), and post-cycle. Blood pressure should be self-monitored weekly throughout the cycle.

PCT: Post-cycle therapy should be initiated based on the ester's half-life clearance window. A SERM protocol (e.g., tamoxifen or clomiphene) is recommended; consult a physician for individualised PCT planning and timing relative to the final injection.

Frequently asked questions

What time of day is best to inject Master Pharma MASS-600?: Morning injections — typically between 07:00 and 10:00 — align with naturally elevated androgen receptor sensitivity and allow the intramuscular depot to begin hydrolysis during peak daytime metabolic activity. Consistency matters more than the exact hour: choosing one fixed daily window and maintaining it throughout the cycle prevents the cumulative trough drift that occurs with variable injection times.
Does the specific day of the week affect MASS-600 cycle results?: Yes. Anchoring injections to fixed calendar days — such as Monday and Thursday — spaces doses evenly at approximately 72-hour intervals, preventing the plasma-level oscillation caused by irregular scheduling. At 600mg/ml, each 0.5ml variance in a draw represents 300mg, so anchor-day discipline directly controls the amplitude of plasma peaks and troughs across the cycle.
Should I inject MASS-600 before or after a training session?: Injecting two to four hours before training is preferred. This window positions the early hydrolysis phase of the depot to coincide with exercise-induced anabolic signalling — specifically the post-mechanical-load elevation in IGF-1 and mTOR pathway activity. Post-training injection is acceptable but introduces a timing lag relative to the peak anabolic window created by resistance work.
How do I calculate the correct draw volume from a 600mg/ml vial?: Divide your target weekly dose in milligrams by 600 to get total weekly millilitres, then divide by injection frequency. For example, a 600mg weekly dose requires 1ml total — 0.5ml per injection on a twice-weekly schedule. Pre-calculating volumes before the cycle starts minimises mid-cycle errors and reduces the number of needle punctures needed across the 10ml vial's lifespan.
What is the maximum number of draws from the MASS-600 10ml vial before sterility risk increases?: Industry aseptic practice recommends limiting multi-dose vial punctures to the number planned at cycle outset, typically no more than 20 draw events for a 10ml vial. Each penetration of the rubber stopper introduces a contamination opportunity; pre-drawn syringes stored in a refrigerator at 2–8 °C for up to 24 hours reduce total puncture count without compromising dose accuracy at this concentration. (2) angle_used

Manufacturer

Production capacity and technological infrastructure at Master Pharma underpin the feasibility of formulating at 600mg/ml — a concentration that demands precise dissolution chemistry, validated fill-finish equipment, and batch-level analytical controls capable of confirming homogeneity at every draw point of a 10ml vial. The facility operates dedicated high-concentration injectable lines equipped with validated mixing and filtration stages, with in-process sampling at defined intervals to confirm concentration consistency before vials proceed to filling. HPLC potency testing against the 600mg/ml label claim and LAL endotoxin assay to parenteral acceptance limits are mandatory release steps; lot-specific certificates of analysis are issued per batch and are traceable to the vial label number. Cleanroom environmental monitoring — covering viable air sampling, non-viable particulate counts, and surface bioburden — is conducted on a scheduled basis and forms part of the permanent batch dossier retained under Master Pharma's GMP-aligned documentation framework.

Product details

Brand	Master Pharma
Active ingredient	mix product
Also known as	Steroid-Mix, Mehrkomponenten-Mischung, Cut Mix, MASS-600, Master Pharma Steroid-Mix
Strength	600 mg
Form	Vial
Pack size	1 piece
Item number	INJ-MIX-MAS-600-014

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Mixobolin-200 200mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Hardcore Cutting

Mixobolin-200 200mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Mixobolin-200 by BM Pharmaceuticals combines Trenbolone Acetate 50mg, Drostanolone Propionate 50mg, and Testosterone Propionate 100mg per millilitre — 200mg/ml total — across 10 individually sealed single-dose glass ampoules, formulated to distribute androgen receptor occupancy across three mechanistically distinct compound classes rather than concentrating binding pressure through a single high-affinity pathway. All three propionate and acetate esters clear within 2–3 days, allowing cycle termination to be executed precisely when training output signals diminishing receptor responsiveness, with post-cycle therapy starting as early as 3–5 days after the final ampoule. Per-compound HPLC quantification and LAL endotoxin screening are applied at batch level; each ampoule is hermetically sealed under nitrogen-blanketed aseptic fill conditions before carton assembly.

€76.00

Recomp Optimizer

Mix Products Injection 250mg/ml 10ml Vial by Genesis

Genesis Mix Products Injection is a 250mg/ml tri-ester hybrid injectable combining Trenbolone Acetate 40mg, Nandrolone Decanoate 90mg, and Testosterone Mix 120mg per ml, formulated specifically to support precise microdosing protocols in a 10ml multi-dose vial. The dual 19-nor structure combined with a testosterone base makes post-cycle therapy exceptionally demanding — users must expect an aggressive, extended SERM regimen beginning approximately 14–21 days after the final injection, timed to the decanoate ester's clearance. Vial integrity, concentration accuracy, and sterility are verified through reversed-phase HPLC quantification and LAL endotoxin testing; every released batch carries a traceable certificate of analysis.

€54.00

Mass Building

NTD 400 400mg/ml 10ml Vial by GenTec

GenTec NTD 400 is a 400mg/ml tri-ester injectable blend — Nandrolone Decanoate 100mg, Drostanolone Enanthate 100mg, Testosterone Enanthate 200mg — formulated specifically for cruise & blast mass-building protocols in a 10ml multi-dose vial. Each millilitre delivers 4,000mg of total active ingredient across the full vial, with long-acting esters sustaining stable plasma levels throughout extended blast phases without the need for daily injections. Quality assurance is enforced through HPLC concentration verification, LAL endotoxin testing, and GMP-compliant aseptic fill-and-finish; batch certificates are available per lot.

€50.00

Best Value

Cut Stack 150 150mg/ml 10ml Vial by Hilma Biocare

Cut Stack 150 by Hilma Biocare is a 150mg/ml injectable cutting blend — Testosterone Propionate 50mg/ml, Trenbolone Acetate 50mg/ml, and Drostanolone Propionate 50mg/ml — supplied in a 10ml multi-dose vial and formulated exclusively for advanced cutting protocols, with an absolute contraindication against TRT or anti-aging use. Because all three compounds carry a 2–3 day half-life, plasma levels fall to sub-suppressive thresholds within days of the final injection, opening the post-cycle recovery window approximately 3–5 days after the last dose — a materially earlier point than long-ester injectable cycles, and driven by ester hydrolysis rather than the hepatic clearance kinetics that govern oral-cycle PCT scheduling. Every production lot is released under Hilma Biocare's analytical framework: HPLC potency confirmation and LAL endotoxin testing applied batch-by-batch, with certificates accessible via the brand's verification portal.

€54.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00